National Cancer Institute

FY 2009 Research Funding by Research Topic

Cancer Type Funded Amount
Agent Orange/Dioxin Related $1,533,826
Aging $145,615,459
Alcoholism Research $612,111
Arctic $593,726
Arthritis $598,527
Ataxia Telangiectasia $4,254,915
Autoimmune Diseases $12,647,422
Basic Behavioral and Social Science $73,144,457
Behavioral and Social Science $304,343,442
Biochemical Epidemiology $238,806,490
Bioengineering $174,624,243
Bone Marrow Transplantation $60,626,760
Cancer $4,966,926,530
Cancer Survivorship $204,727,050
Cervical Cancer Education $5,296,283
Chemoprevention $160,985,495
Chemotherapy $528,665,822
Childhood Cancers $192,844,826
Chronic Myeloproliferative Disorders $32,529,168
Contraception and Reproduction Research $3,781,431
Depression Research $9,772,716
Diabetes $7,777,842
Digestive Diseases $450,822,745
Down Syndrome $893,179
Gene Therapy $68,363,970
Gene Therapy Clinical Trials $13,128,308
Genetic Testing $133,833,813
Herpes - Genital $572,349
Herpes - Other $57,349,764
Inflammatory Bowel Disease $3,212,447
Interferon $15,096,924
Metastasis $387,260,786
Neurofibromatosis $8,245,707
Nuclear Magnetic Resonance Imaging (NMR) $79,391,754
Nursing Oncology $17,803,993
Organ Transplantation Research $77,809,088
Pesticides $3,005,323
Sleep Disorders $8,019,892
Smoking Behavior $66,024,665
Surgery $70,765,789
Taxol $69,699,847
Tuberous Sclerosis $4,120,931